Lisa K. Brents

Assistant Professor

University of Arkansas for Medical Sciences

faculty

17 h-index 52 pubs 1,507 cited

Research Areas

Neuroscience and Neuropharmacology Research Substance Abuse Treatment and Outcomes Birth, Development, and Health Maternal and Perinatal Health Interventions Behavioral and Psychological Studies Pharmacological Effects and Toxicity Studies Health and Medical Research Impacts

Links

ORCID Lab Website UAMS TRI Profile

Is this your profile? Verify and claim your profile

OverviewAI-generated summary

Lisa K. Brents investigates the effects of substances on behavior and physiological responses in animal models. Her research has examined how environmental factors, such as limited bedding, influence ethanol consumption in female rats. Brents also studies the pharmacodynamics of substances like buprenorphine and its metabolites, including their impact on neonatal opioid withdrawal syndrome and fentanyl effects in pregnant rats. She has analyzed public responses to regulatory inquiries regarding kratom, focusing on self-medication motives. Brents' work also includes the automated quantification of opioid withdrawal symptoms in neonatal rat pups using specialized software. She collaborates with researchers at the University of Arkansas for Medical Sciences, including Brian J. Parks, Julia Tobacyk, Kyounghyun Kim, and Michael D. Berquist, with whom she has co-authored multiple publications. Brents' scholarship metrics include an h-index of 17, 52 total publications, and 1,507 total citations.

Metrics

  • h-index: 17
  • Publications: 52
  • Citations: 1,507

Selected Publications

  • Deuterated Buprenorphine Mitigates Fentanyl Effects in Pregnant Rats (2024) DOI
  • Limited bedding and nesting increases ethanol drinking in female rats (2024) DOI
  • Interaction between buprenorphine and norbuprenorphine in neonatal opioid withdrawal syndrome (2023) DOI
  • Deuterated buprenorphine retains pharmacodynamic properties of buprenorphine and resists metabolism to the active metabolite norbuprenorphine in rats (2023) DOI
  • Effects of a two-hit model of early life adversity on oral ethanol self-administration and adrenergic receptor expression in adolescent rats (2023) DOI
  • 481 Interactions between buprenorphine and norbuprenorphine in neonatal opioid withdrawal syndrome (2023) DOI
  • Response to article – alternative interpretation of “there is reduced immunohistochemical staining of placental aromatase in severe neonatal opioid withdrawal syndrome” (2023) DOI
  • Interaction between buprenorphine and norbuprenorphine in neonatal opioid withdrawal syndrome. (2022) DOI
  • Deuterated buprenorphine retains pharmacodynamic properties of buprenorphine and resists metabolism to the active metabolite norbuprenorphine in rats (2022) DOI
  • Qualitative content analysis of public responses to an FDA inquiry on the impact of scheduling changes to kratom (2022) DOI
  • Effects of prenatal opioid exposure and early life adversity on opioid‐induced antinociception (2022) DOI
  • 384 Motives for kratom self-medication: contents of public comments solicited by the FDA (2022) DOI
  • Automated quantification of opioid withdrawal in neonatal rat pups using Ethovision® XT software (2021) DOI

Grants & Funding

Collaborators

Researchers in the database who share publications

Brian J. Parks University of Arkansas for Medical Sciences 11 shared publications Julia Tobacyk University of Arkansas for Medical Sciences 10 shared publications Kyounghyun Kim University of Arkansas for Medical Sciences 10 shared publications Michael D. Berquist University of Arkansas for Medical Sciences 7 shared publications Saki Fukuda University of Arkansas for Medical Sciences 2 shared publications Jeffery H. Moran University of Arkansas for Medical Sciences 2 shared publications Alexander W. Alund National Center for Toxicological Research 2 shared publications Madison McGraw University of Arkansas for Medical Sciences 2 shared publications

Similar Researchers

Based on overlapping research topics

Michael D. Berquist University of Arkansas for Medical Sciences
Neuroscience and Neuropharmacology Research Substance Abuse Treatment and Outcomes Maternal and Perinatal Health Interventions
Strong match 5 shared topics
Brian J. Parks University of Arkansas for Medical Sciences
Neuroscience and Neuropharmacology Research Substance Abuse Treatment and Outcomes Maternal and Perinatal Health Interventions
Good match 5 shared topics
Cassie M. Chandler University of Arkansas for Medical Sciences
Neuroscience and Neuropharmacology Research Substance Abuse Treatment and Outcomes Behavioral and Psychological Studies
Good match 5 shared topics
James C. Douglas University of Arkansas for Medical Sciences
Neuroscience and Neuropharmacology Research Substance Abuse Treatment and Outcomes Birth, Development, and Health
Good match 5 shared topics
John J. Chelonis National Center for Toxicological Research
Neuroscience and Neuropharmacology Research Birth, Development, and Health Maternal and Perinatal Health Interventions
Good match 5 shared topics
William M. Blakemore National Center for Toxicological Research
Neuroscience and Neuropharmacology Research Substance Abuse Treatment and Outcomes Behavioral and Psychological Studies
Good match 4 shared topics